糖尿病大血管并发症危险因素及干预对策

被引：62

作者：

杨兵全

范振华

机构：

[1] 东南大学附属中大医院内分泌科

[2] 南京七三四厂职工医院内科

来源：

国外医学内分泌学分册. | 2002年 / 02期

关键词：

糖尿病; 大血管并发症; 危险因素; 预防;

D O I：

暂无

中图分类号：

R587.1 [糖尿病];

学科分类号：

摘要：

糖尿病大血管并发症是糖尿病致死致残的主要原因,目前相关基础和临床研究较多,近年来的临床流行病学研究认为:高血糖、高血脂/脂蛋白血症、高血压、高胰岛素血症及胰岛素抵抗、肥胖、吸烟等是糖尿病大血管并发症的主要危险因素。理想血糖、血压控制、调节血脂水平、加强抗凝治疗、减轻体重和戒烟等是预防和治疗糖尿病大血管并发症的有效手段。

引用

页码：69 / 72

页数：4

共 10 条

[1] Intensiveblood-glucosecontrolwithsulfonylureasofinsulincompareswithconventionaltreatmentandrisksofcomplicationsinpatientswithtype2diabetes(UKPDS:33)犤J犦. UKPDSGroup. The Lancet . 1998
[2] Tightbloodpressurecontrolandriskofmacrovascularcomplica-tionsintype2diabetes:UKPDS38犤J犦. UKProspectiveDiabetesStudyGroup. British Medical Journal . 1998
[3] Dia-betesandcardiovasculardisease.AstatementforhealthcareprofessionalsfromtheAmericanHeartAssociation犤J犦. GrundySM,BenjaminIJ,BurkeGL,etal. Circulation . 1999
[4] ShapedandJ-shapedrelationshipsbetweenseruminsulinandcoronaryheartdiseaseinthegeneralpopulation:theBruneckStudy犤J犦. BonoraE,WilleitJ,KiechlS,etal. Diabetes Care . 1998
[5] Pre-dictorsofmacrovasculardiseaseinpatientswithtype2diabetesmellitus犤J犦. Abu-lebdenHS,HodgeDO,NguyenTT,etal. Mayo Clinic Proceedings . 2001
[6] Riskfactorsforcoronaryarterydiseaseinnon-insulinde-pendentdiabetesmellitus:UnitedKingdomProspec-tiveDiabetesStudy(UKPDS:23)犤J犦. TurnerRC,MillnsH,NeilHAW,etal. British Medical Journal . 1998
[7] Re-lationofglycohemoglobinandadiposityinyouth犤J犦. McGillHC,McMahanA,MalcolmGT,etal. Arteriosclerosis Thrombosis and Vascular Biology . 1999
[8] Associationofglycaemiawithmacrovascularandmicrovascularcom-plicationoftype2diabetes(UKPDS:35):prospectiveobservationalstudy犤J犦. StrattonIM,AdlerAI,NeilHA. British Medical Journal . 2000
[9] Associationofsystolicbloodpressurewithmacrovascularandmicrovascularcomplicationsoftype2diabetes(UKPDS:36):prospectiveobservationstudy犤J犦. AdlerAI,StrattonIM,NeilHA,etal. BritMed . 2000
[10] Intensiveblood-glucosecontrolwithsulphonylureasorinsulincomparedwithconventionaltreatmentandriskofcomplicationsinpatientswithtype2diabetes(UKPDS:33)犤J犦. UKPDSGroup. The Lancet . 1998

← 1 →